CTLA4 and melanoma: Moreover, in one study, it was demonstrated that the expression of PD-L1 on histiocytes in patients with ovarian cancer and melanoma correlated with the efficacy of treatment with either anti-PD-1 alone or in combination with anti-CTLA-4 [35].